Abstract
The present disclosure relates to polypeptide molecules that specifically bind T cell receptor beta and compositions and methods comprising and employing the same.
Full Text
What is claimed is:
The present disclosure relates to polypeptide molecules that specifically bind T cell receptor beta and compositions and methods comprising and employing the same.
Timeline
Filed
04/20/2026Published
08/13/2026Granted
Not AvailableIPC Codes(5)
C07K 16/28:against receptors, cell surface antigens or cell surface determinants
A61K 38/00:Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K 31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K 31/00; ergoline-based peptides A61K 31/48; containing macromolecular compounds having statistically distributed amino acid units A61K 31/74; medicinal preparations containing antigens or antibodies A61K 39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K 47/00)
A61P 37/04:Immunostimulants